Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jorge Vela-Ojeda

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Geographic Areas

Mexico

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Anatomy

Hematopoietic Stem Cells

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Majluf-Cruz Abraham; Moreno-Hernández Manuel; Ruiz-de-Chávez-Ochoa Adriana; Monroy-García Rosario; Majluf-Cruz Karim; Guardado-Mendoza Rodolfo; Molina-Avila Irma; Isordia-Salas Irma; Corona-de la Peña Norma; Vargas-Vorackova Florencia; Vela-Ojeda Jorge; García-Chávez Jaime
Activated protein C resistance and factor V Leiden in Mexico.
Shah Neil P; Kantarjian Hagop M; Kim Dong-Wook; Réa Delphine; Dorlhiac-Llacer Pedro E; Milone Jorge H; Vela-Ojeda Jorge; Silver Richard T; Khoury H Jean; Charbonnier Aude; Khoroshko Nina; Paquette Ronald L; Deininger Michael; Collins Robert H; Otero Irma; Hughes Timothy; Bleickardt Eric; Strauss Lewis; Francis Stephen; Hochhaus Andreas
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
Majluf-Cruz Abraham; Moreno-Hernández Manuel; Martínez-Esquivel Noemí; Ruiz de Chávez-Ochoa Adriana Aurelia; Coria-Ramírez Erika; Monroy-García Rosario; Vela-Ojeda Jorge; García-Chávez Jaime; Basave-Rojas Marcelo; Villasís-Keeverd Miguel Angel
[Factor VIII activity among young Mexican patients with acute myocardial infarction]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jorge Vela-Ojeda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Majluf-Cruz Abraham; Moreno-Hernández Manuel; Ruiz-de-Chávez-Ochoa Adriana; Monroy-García Rosario; Majluf-Cruz Karim; Guardado-Mendoza Rodolfo; Molina-Avila Irma; Isordia-Salas Irma; Corona-de la Peña Norma; Vargas-Vorackova Florencia; Vela-Ojeda Jorge; García-Chávez Jaime
Activated protein C resistance and factor V Leiden in Mexico.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(4):428-37.
2008: Shah Neil P; Kantarjian Hagop M; Kim Dong-Wook; Réa Delphine; Dorlhiac-Llacer Pedro E; Milone Jorge H; Vela-Ojeda Jorge; Silver Richard T; Khoury H Jean; Charbonnier Aude; Khoroshko Nina; Paquette Ronald L; Deininger Michael; Collins Robert H; Otero Irma; Hughes Timothy; Bleickardt Eric; Strauss Lewis; Francis Stephen; Hochhaus Andreas
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3204-12.
2008: Majluf-Cruz Abraham; Moreno-Hernández Manuel; Martínez-Esquivel Noemí; Ruiz de Chávez-Ochoa Adriana Aurelia; Coria-Ramírez Erika; Monroy-García Rosario; Vela-Ojeda Jorge; García-Chávez Jaime; Basave-Rojas Marcelo; Villasís-Keeverd Miguel Angel
[Factor VIII activity among young Mexican patients with acute myocardial infarction]
Gaceta médica de México 2008;144(3):199-206.
2007: Garcia-Chavez Jaime; Majluf-Cruz Abraham; Montiel-Cervantes Laura; Esparza Miriam García-Ruiz; Vela-Ojeda Jorge;
Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
Annals of hematology 2007;86(12):871-7.
2007: Vela-Ojeda J; García-Ruiz-Esparza M A; Padilla-González Y; Gómez-Almaguer D; Gutiérrez-Aguirre C H; Gómez-Rangel D; Morales-Toquero A; Ruiz-Delgado G J; Delgado-Lamas J L; Ruiz-Argüelles G J
Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan.
Annals of hematology 2007;86(4):277-82.
2007: Martínez-Jaramillo Guadalupe; Vela-Ojeda Jorge; Sánchez-Valle Elizabeth; Montesinos Juan José; Mayani Hector
In vitro functional alterations in the hematopoietic system of adult patients with acute lymphoblastic leukemia.
Leukemia research 2007;31(1):83-9.
2006: Vega Sara; Reyes-Maldonado Elba; Vela-Ojeda Jorge; Xolotl-Castillo Moisés; Montiel-Cervantes Laura; Cerecedo-Mercado Doris A
[Ultrastructural study of platelets patients with paroxysmal nocturnal hemoglobinuria]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2006;58(5):475-86.
2006: Vela-Ojeda J; García-Ruiz Esparza M A; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León L D; Borbolla-Escoboza J R
Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma.
Annals of hematology 2006;85(5):308-14.
2006: Gómez-Almaguer David; Vela-Ojeda Jorge; Jaime-Pérez José C; Gutiérrez-Aguirre César H; Cantú-Rodríguez Olga G; Sobrevilla-Calvo Pedro; Rivas-Vera Silvia; Gómez-Rangel J David; Ruiz-Argüelles Guillermo J
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
American journal of hematology 2006;81(3):157-61.
2006: Chávez-González Antonieta; Ayala-Sánchez Manuel; Sánchez-Valle Elizabeth; Ruiz-Sánchez Elizabeth; Arana-Trejo Rosa María; Vela-Ojeda Jorge; Mayani Hector
Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
Leukemia research 2006;30(3):286-95.
2006: Vela-Ojeda J; García-Ruiz Esparza M A; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León L D; Borbolla-Escoboza J R; Mayani H
Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.
Annals of hematology 2006;85(2):113-20.
2005: Ruiz-Argüelles G J; Gómez-Almaguer D; Morales-Toquero A; Gutiérrez-Aguirre C H; Vela-Ojeda J; García-Ruiz-Esparza M A; Manzano C; Karduss A; Sumoza A; de-Souza C; Miranda E; Giralt S;
The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter study.
Bone marrow transplantation 2005;36(12):1043-7.
2005: Ruiz-Argüelles Guillermo J; Gómez-Almaguer David; Vela-Ojeda Jorge; Morales-Toquero Amelia; Gómez-Rangel Jóse David; García-Ruiz-Esparza Miriam A; López-Martínez Briceida; Cantú-Rodríguez Olga G; Gutiérrez-Aguirrec César H
Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.
International journal of hematology 2005;82(3):262-5.
2005: Vela-Ojeda J; Esparza M A García-Ruiz; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León L D; Borbolla-Escoboza J R
CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donors.
Stem cells and development 2005;14(3):310-6.
2005: Vela-Ojeda Jorge; Ruiz-Esparza Miriam A García
[Hematopoietic stem cell transplantation in multiple myeloma]
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2005;57(2):305-13.
2004: Vela-Ojeda J; García-Ruiz Esparza M A; Tripp-Villanueva F; Ayala-Sánchez M; Delgado-Lamas J L; Garcés-Ruiz O; Rubio-Jurado B; Montiel-Cervantes L; Sánchez-Cortés E; García-Chavez J; Xolotl-Castillo M; Rosas-Cabral A; Salazar-Exaire D; Galindo-Rodríguez G; Aviña-Zubieta A
Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia.
Stem cells and development 2004;13(5):571-9.
2004: Ruiz-Argüelles Guillermo J; Gómez-Almaguer David; David-Gomez-Rangel Jose; Vela-Ojeda Jorge; Cantú-Rodríguez Olga G; Jaime-Pérez José C; González-Llano Oscar; Herrera-Garza José L
Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study.
Leukemia & lymphoma 2004;45(6):1191-5.
2004: Chávez-González Antonieta; Rosas-Cabral Alejandro; Vela-Ojeda Jorge; González José Carlos; Mayani Hector
Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
Leukemia research 2004;28(6):639-47.
2004: Vela-Ojeda J; García-Ruiz Esparza M A; Reyes-Maldonado E; Jiménez-Zamudio L; Moreno-Lafont M; García-Latorre E; Ramírez-Sanjuan E; Montiel-Cervantes L; Tripp-Villanueva F; García-León L D; Ayala-Sánchez M; Rosas-Cabral A; Aviña-Zubieta J A; Galindo-Rodríguez G; Vadillo-Buenfil M; Salazar-Exaire D
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3(+) and CD4(+) lymphocytes.
Annals of hematology 2004;83(5):295-301.
2003: Rosas-Cabral Alejandro; Martínez-Mancilla Manuel; Ayala-Sánchez Manuel; Vela-Ojeda Jorge; Bahena-Reséndiz Patricia; Vadillo-Buenfil Manuel; Aviña-Zubieta J Antonio; Salazar-Exaire Daniel; Miranda-Peralta Enrique; Marroquín Alberto; Longoria-Revilla Ernesto
[Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia]
Gaceta médica de México 2003;139(6):553-9.
2003: Galindo-Rodríguez Griselda; Bustamante Reyna; Esquivel-Nava Gerardo; Salazar-Exaire Daniel; Vela-Ojeda Jorge; Vadillo-Buenfil Manuel; Aviña-Zubieta J Antonio
Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis.
The Journal of rheumatology 2003;30(11):2382-4.
2003: Rosas-Cabral Alejandro; Irigoyen Lourdes; Alvarado Lilia; Vela-Ojeda Jorge; Ayala-Sánchez Manuel; Tripp-Villanueva Francisco; Sánchez Evelia; Gonzalez-Llaven José; Gariglio Patricio
HLA CW3 and HLA CW4 have a protective effect on acquisition of chronic myeloid leukemia on Mexican patients.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2003;55(4):423-8.
2003: Aviña-Zubieta J A; Galindo-Rodrìguez G; Robledo I; Vela-Ojeda J; Vadillo-Buenfil M; Rosas-Cabral A; Salazar-Exaire D
Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus.
Lupus 2003;12(1):52-7.
2002: Vela-Ojeda J; García-Ruiz Esparza M A; Padilla-González Y; Rosas-Cabral A; García-Chávez J; Xolotl-Castillo M; Salazar-Exaire D; Arenas-Osuna J; Aviña-Zubieta J A; Vadillo-Buenfil M; Abraham-Majluf S
IFN-alpha as induction and maintenance treatment of patients newly diagnosed with Waldenström's macroglobulinemia.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(10):1013-6.
2002: Vela-Ojeda J; García-Ruiz Esparza M A; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León L D; Montiel-Cervantes L; Rubio-Borja M E
Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Annals of hematology 2002;81(7):362-7.
2000: Vela-Ojeda J; Tripp-Villanueva F; Montiel-Cervantes L; Sánchez-Cortés E; Ayala-Sánchez M; Guevara-Moreno M E; García-León L D; Rosas-Cabral A; Esparza M A; González-Llaven J
Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.
Bone marrow transplantation 2000;25(11):1141-6.
2000: Vela-Ojeda J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; Rosas-Cabral A; Esparza M G; García-Chávez J; García-León L D; González-Llaven J
Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience.
Archives of medical research 2000;31(2):206-9.
1999: Vela-Ojeda J; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza M A; Rosas-Cabral A; Gonzalez-Llaven J
Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant.
Bone marrow transplantation 1999;24(12):1307-10.
1999: Vela-Ojeda J; Diaz de León L; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza M A; Rosas-Cabral A; Gonzalez-Llaven J
Malignant fibrous histiocytoma after allogeneic bone marrow transplantation.
Bone marrow transplantation 1999;24(9):1029-31.
1999: González-Llaven J; Palma-Aguirre J A; García-Arreola R; Brizuela V; Nava-Rangel J; Morán-Lira S; Vela-Ojeda J; Castañeda-Hernández G; Flores-Murrieta F J
Comparative bioavailability evaluation of two cyclosporine oral formulations in healthy Mexican volunteers.
Archives of medical research 1999;30(4):315-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jorge Vela-Ojeda

Research Profile (preview)

Procedures

Disorders

Geographic Areas

Concepts & Ideas

Chemicals & Drugs

Phenomena

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jorge Vela-Ojeda (preview)

All Publications